Extranodal NK-T-cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
(New page: {{Infobox Disease | Name = {{PAGENAME}} | Image = | Caption = | DiseasesDB = | ICD10 = | ICD9 = | ICDO = {{ICDO|9719|...) |
No edit summary |
||
| Line 13: | Line 13: | ||
| MeshID = D054391 | | MeshID = D054391 | ||
}} | }} | ||
{{SI}} | |||
{{EH}} | |||
'''Extranodal NK-T-cell lymphoma''' is a type of [[lymphoma]].<ref name="pmid16380410">{{cite journal |author=Lee J, Suh C, Park YH, ''et al'' |title=Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study |journal=J. Clin. Oncol. |volume=24 |issue=4 |pages=612–8 |year=2006 |month=February |pmid=16380410 |doi=10.1200/JCO.2005.04.1384 |url=http://www.jco.org/cgi/pmidlookup?view=long&pmid=16380410}}</ref><ref name="pmid15963893">{{cite journal |author=Lee J, Park YH, Kim WS, ''et al'' |title=Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy |journal=Eur. J. Cancer |volume=41 |issue=10 |pages=1402–8 |year=2005 |month=July |pmid=15963893 |doi=10.1016/j.ejca.2005.03.010 |url=http://linkinghub.elsevier.com/retrieve/pii/S0959-8049(05)00218-2}}</ref><ref name="pmid19041057">{{cite journal |author=Lee J, Au WY, Park MJ, ''et al'' |title=Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study |journal=Biol. Blood Marrow Transplant. |volume=14 |issue=12 |pages=1356–64 |year=2008 |month=December |pmid=19041057 |doi=10.1016/j.bbmt.2008.09.014 |url=http://linkinghub.elsevier.com/retrieve/pii/S1083-8791(08)00405-9}}</ref> | '''Extranodal NK-T-cell lymphoma''' is a type of [[lymphoma]].<ref name="pmid16380410">{{cite journal |author=Lee J, Suh C, Park YH, ''et al'' |title=Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study |journal=J. Clin. Oncol. |volume=24 |issue=4 |pages=612–8 |year=2006 |month=February |pmid=16380410 |doi=10.1200/JCO.2005.04.1384 |url=http://www.jco.org/cgi/pmidlookup?view=long&pmid=16380410}}</ref><ref name="pmid15963893">{{cite journal |author=Lee J, Park YH, Kim WS, ''et al'' |title=Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy |journal=Eur. J. Cancer |volume=41 |issue=10 |pages=1402–8 |year=2005 |month=July |pmid=15963893 |doi=10.1016/j.ejca.2005.03.010 |url=http://linkinghub.elsevier.com/retrieve/pii/S0959-8049(05)00218-2}}</ref><ref name="pmid19041057">{{cite journal |author=Lee J, Au WY, Park MJ, ''et al'' |title=Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study |journal=Biol. Blood Marrow Transplant. |volume=14 |issue=12 |pages=1356–64 |year=2008 |month=December |pmid=19041057 |doi=10.1016/j.bbmt.2008.09.014 |url=http://linkinghub.elsevier.com/retrieve/pii/S1083-8791(08)00405-9}}</ref> | ||
Revision as of 05:28, 20 February 2009
| Extranodal NK-T-cell lymphoma | |
| ICD-O: | Template:ICDO |
|---|---|
| MeSH | D054391 |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Extranodal NK-T-cell lymphoma is a type of lymphoma.[1][2][3]
It is called "extranodal" to emphasize that the location is not in the lymph node. It is sometimes further qualified as "nasal type".
It can be associated with Epstein Barr virus.[4][5]
RNAi against EBNA1 has been proposed as a possible treatment.[6]
References
- ↑ Lee J, Suh C, Park YH; et al. (2006). "Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study". J. Clin. Oncol. 24 (4): 612–8. doi:10.1200/JCO.2005.04.1384. PMID 16380410. Unknown parameter
|month=ignored (help) - ↑ Lee J, Park YH, Kim WS; et al. (2005). "Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy". Eur. J. Cancer. 41 (10): 1402–8. doi:10.1016/j.ejca.2005.03.010. PMID 15963893. Unknown parameter
|month=ignored (help) - ↑ Lee J, Au WY, Park MJ; et al. (2008). "Autologous hematopoietic stem cell transplantation in extranodal natural killer/T cell lymphoma: a multinational, multicenter, matched controlled study". Biol. Blood Marrow Transplant. 14 (12): 1356–64. doi:10.1016/j.bbmt.2008.09.014. PMID 19041057. Unknown parameter
|month=ignored (help) - ↑ Stadlmann S, Fend F, Moser P, Obrist P, Greil R, Dirnhofer S (2001). "Epstein-Barr virus-associated extranodal NK/T-cell lymphoma, nasal type of the hypopharynx, in a renal allograft recipient: case report and review of literature". Hum. Pathol. 32 (11): 1264–8. PMID 11727268. Unknown parameter
|month=ignored (help) - ↑ Ferenczi K, Summers P, Aubert P; et al. (2008). "A case of CD30+ nasal natural killer/T-cell lymphoma". Am J Dermatopathol. 30 (6): 567–71. doi:10.1097/DAD.0b013e318184bc3f. PMID 19033930. Unknown parameter
|month=ignored (help) - ↑ Ian MX, Lan SZ, Cheng ZF, Dan H, Qiong LH (2008). "Suppression of EBNA1 expression inhibits growth of EBV-positive NK/T cell lymphoma cells". Cancer Biol. Ther. 7 (10): 1602–6. PMID 18769118. Unknown parameter
|month=ignored (help)